Jean‐Claude Cutz
- Molecular Biology
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 5%
- Immunology
- Topics
- Prostate Cancer Treatment and Research (9 papers)Lung Cancer Treatments and Mutations (6 papers)Epigenetics and DNA Methylation (5 papers)
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Jean‐Claude Cutz
44 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 666
- Oncology 403
- Pulmonary and Respiratory Medicine 370
- Cancer Research 319
- Immunology 104
Countries citing papers authored by Jean‐Claude Cutz
This map shows the geographic impact of Jean‐Claude Cutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Claude Cutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Claude Cutz more than expected).
Fields of papers citing papers by Jean‐Claude Cutz
This network shows the impact of papers produced by Jean‐Claude Cutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Claude Cutz. The network helps show where Jean‐Claude Cutz may publish in the future.
Co-authorship network of co-authors of Jean‐Claude Cutz
This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Claude Cutz. A scholar is included among the top collaborators of Jean‐Claude Cutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Claude Cutz. Jean‐Claude Cutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 7 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 34 | |
| 8 | 20 | |
| 9 | 40 | |
| 10 | 34 | |
| 11 | 0 | |
| 12 | 20 | |
| 13 | 15 | |
| 14 | 90 | |
| 15 | 53 | |
| 16 | 44 | |
| 17 | 36 | |
| 18 | 75 | |
| 19 | 92 | |
| 20 | Potential use for sulfasalazine in lung cancer therapy | 1 |
About Jean‐Claude Cutz
Jean‐Claude Cutz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 45 papers that have together received 1.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (319 citations), Oncology (403 citations) and Pulmonary and Respiratory Medicine (370 citations). Jean‐Claude Cutz has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Damu Tang, Anil Kapoor, Lizhi He, Adrian P. Rybak, Jane Bayani, Jeremy A. Squire, Hui Xue, Yuzhuo Wang, Maisa Yoshimoto and Catherine Fan. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.